150 related articles for article (PubMed ID: 37344127)
21. Malignant Bowel Obstruction in Patients With Recurrent Ovarian Cancer.
Tran E; Spiceland C; Sandhu NP; Jatoi A
Am J Hosp Palliat Care; 2016 Apr; 33(3):272-5. PubMed ID: 25552305
[TBL] [Abstract][Full Text] [Related]
22. Palliative treatment for bowel obstruction in ovarian cancer: a meta-analysis.
Jin M; Shen F; Li M; Chen Y
Arch Gynecol Obstet; 2020 Jul; 302(1):241-248. PubMed ID: 32445066
[TBL] [Abstract][Full Text] [Related]
23. Malignant bowel obstruction due to uterine or ovarian cancer: Are there differences in outcome?
Hoppenot C; Peters P; Cowan M; Moore ED; Hurteau J; Lee NK; Yamada SD
Gynecol Oncol; 2019 Jul; 154(1):177-182. PubMed ID: 31056111
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Diagnosis and Management of Malignant Bowel Obstruction: A Review.
Demarest K; Lavu H; Collins E; Batra V
J Pain Palliat Care Pharmacother; 2023 Mar; 37(1):91-105. PubMed ID: 36377820
[TBL] [Abstract][Full Text] [Related]
25. MASCC multidisciplinary evidence-based recommendations for the management of malignant bowel obstruction in advanced cancer.
Madariaga A; Lau J; Ghoshal A; Dzierżanowski T; Larkin P; Sobocki J; Dickman A; Furness K; Fazelzad R; Crawford GB; Lheureux S
Support Care Cancer; 2022 Jun; 30(6):4711-4728. PubMed ID: 35274188
[TBL] [Abstract][Full Text] [Related]
26. Octreotide in the management of bowel obstruction in terminal ovarian cancer.
Mangili G; Franchi M; Mariani A; Zanaboni F; Rabaiotti E; Frigerio L; Bolis PF; Ferrari A
Gynecol Oncol; 1996 Jun; 61(3):345-8. PubMed ID: 8641613
[TBL] [Abstract][Full Text] [Related]
27. A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer.
Chi DS; Phaëton R; Miner TJ; Kardos SV; Diaz JP; Leitao MM; Gardner G; Huh J; Tew WP; Konner JA; Sonoda Y; Abu-Rustum NR; Barakat RR; Jaques DP
Oncologist; 2009 Aug; 14(8):835-9. PubMed ID: 19684071
[TBL] [Abstract][Full Text] [Related]
28. The range and suitability of outcome measures used in the assessment of palliative treatment for inoperable malignant bowel obstruction: A systematic review.
Bravington A; Obita G; Baddeley E; Johnson MJ; Murtagh FE; Currow DC; Boland EG; Nelson A; Seddon K; Oliver A; Noble SI; Boland JW
Palliat Med; 2022 Oct; 36(9):1336-1350. PubMed ID: 36131489
[TBL] [Abstract][Full Text] [Related]
29. Possible role of palliative surgery for bowel obstruction in advanced ovarian cancer patients.
Sartori E; Chiudinelli F; Pasinetti B; Sostegni B; Maggino T
Eur J Gynaecol Oncol; 2010; 31(1):31-6. PubMed ID: 20349778
[TBL] [Abstract][Full Text] [Related]
30. [Management of malignant bowel obstruction in terminal care--is home care possible?].
Sasson M; Shvartzman P
Harefuah; 1998 May; 134(10):757-9, 832. PubMed ID: 10909630
[TBL] [Abstract][Full Text] [Related]
31. Bowel obstruction in elderly ovarian cancer patients: a population-based study.
Mooney SJ; Winner M; Hershman DL; Wright JD; Feingold DL; Allendorf JD; Neugut AI
Gynecol Oncol; 2013 Apr; 129(1):107-12. PubMed ID: 23274561
[TBL] [Abstract][Full Text] [Related]
32. Malignant bowel obstruction: so much more than symptom control.
Platt V
Int J Palliat Nurs; 2001 Nov; 7(11):547-54. PubMed ID: 11775930
[TBL] [Abstract][Full Text] [Related]
33. Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma.
Pothuri B; Montemarano M; Gerardi M; Shike M; Ben-Porat L; Sabbatini P; Barakat RR
Gynecol Oncol; 2005 Feb; 96(2):330-4. PubMed ID: 15661217
[TBL] [Abstract][Full Text] [Related]
34. Surgical management of malignant bowel obstruction: strategies toward palliation of patients with advanced cancer.
DeBernardo R
Curr Oncol Rep; 2009 Jul; 11(4):287-92. PubMed ID: 19508833
[TBL] [Abstract][Full Text] [Related]
35. Management of large bowel obstruction in advanced ovarian cancer with intraluminal stents.
Carter J; Valmadre S; Dalrymple C; Atkinson K; Young C
Gynecol Oncol; 2002 Jan; 84(1):176-9. PubMed ID: 11748998
[TBL] [Abstract][Full Text] [Related]
36. Management of intestinal obstruction in ovarian cancer.
Krebs HB; Helmkamp BF
Oncology (Williston Park); 1989 May; 3(5):25-31; discussion 31-2, 35-6. PubMed ID: 2491443
[TBL] [Abstract][Full Text] [Related]
37. End-of-Life Characteristics Associated With Short Hospice Length of Stay for Patients With Solid Tumors Enrolled in Phase I Clinical Trials.
Sedhom R; Blackford AL; Gupta A; Griffiths K; Heussner J; Carducci MA
J Natl Compr Canc Netw; 2021 Jan; 19(6):686-692. PubMed ID: 33477113
[TBL] [Abstract][Full Text] [Related]
38. Management of intestinal obstruction in ovarian cancer.
Krebs HB; Helmkamp F
Oncology (Williston Park); 1989 May; 3(5):25-31; discussion 31-2, 35-6. PubMed ID: 2577883
[TBL] [Abstract][Full Text] [Related]
39. Symptom control in advanced cancer.
Storey P
Semin Oncol; 1994 Dec; 21(6):748-53. PubMed ID: 7992090
[TBL] [Abstract][Full Text] [Related]
40. Malignant bowel obstruction.
Krouse RS
J Surg Oncol; 2019 Jul; 120(1):74-77. PubMed ID: 30908650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
